|
|
||||||||
INFLAMMATION/IMMUNITY/MEDIATORS
Departments of 1Medicine, 3Surgery, and 4Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226; and 2Department of Medicine B, University of Münster, Münster 48149, Germany
Submitted 25 September 2003 ; accepted in final form 23 January 2004
Mice genetically deficient in the chemokine receptor CXCR4 or its ligand stromal cell-derived factor (SDF)-1/CXCL12 die perinatally with marked defects in vascularization of the gastrointestinal tract. The aim of this study was to define the expression and angiogenic functions of microvascular CXCR4 and SDF-1/CXCL12 in the human intestinal tract. Studies of human colonic mucosa in vivo and primary cultures of human intestinal microvascular endothelial cells (HIMEC) in vitro showed that the intestinal microvasculature expresses CXCR4 and its cognate ligand SDF-1/CXCL12. Moreover, SDF-1/CXCL12 stimulation of HIMEC triggers CXCR4-linked G proteins, phosphorylates ERK1/2, and activates proliferative and chemotactic responses. Pharmacological studies indicate SDF-1/CXCL12 evokes HIMEC chemotaxis via activation of ERK1/2 and phosphoinositide 3-kinase signaling pathways. Consistent with chemotaxis and proliferation, endothelial tube formation was inhibited by neutralizing CXCR4 or SDF-1/CXCL12 antibodies, as well as the ERK1/2 inhibitor PD-98059. Taken together, these data demonstrate an important mechanistic role for CXCR4 and SDF-1/CXCL12 in regulating angiogenesis within the human intestinal mucosa.
chemokine; intestinal vascularization; chemotaxis; proliferation
This article has been cited by other articles:
![]() |
D. G. Binion, J. Heidemann, M. S. Li, V. M. Nelson, M. F. Otterson, and P. Rafiee Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF-{kappa}B: inhibitory role of curcumin Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G259 - G268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Horowitz, D. G. Binion, V. M. Nelson, Y. Kanaa, P. Javadi, Z. Lazarova, C. Andrekopoulos, B. Kalyanaraman, M. F. Otterson, and P. Rafiee Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1323 - G1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, S. Basu, M.-K. Han, Y.-J. Kim, and H. E. Broxmeyer Influence of ERK activation on decreased chemotaxis of mature human cord blood monocyte-derived dendritic cells to CCL19 and CXCL12 Blood, April 15, 2007; 109(8): 3173 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Heidemann, W. Domschke, T. Kucharzik, and C. Maaser Intestinal Microvascular Endothelium and Innate Immunity in Inflammatory Bowel Disease: a Second Line of Defense? Infect. Immun., October 1, 2006; 74(10): 5425 - 5432. [Full Text] [PDF] |
||||
![]() |
D. J Kelly, Y. Zhang, R. M Gow, S. Itescu, and R. E Gilbert Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes Diabetes and Vascular Disease Research, May 1, 2005; 2(2): 76 - 80. [Abstract] [PDF] |
||||
![]() |
J. M. Smith, P. A. Johanesen, M. K. Wendt, D. G. Binion, and M. B. Dwinell CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G316 - G326. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, et al. CXCL12 and Vascular Endothelial Growth Factor Synergistically Induce Neoangiogenesis in Human Ovarian Cancers Cancer Res., January 15, 2005; 65(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |